St. Jude develops new vaccine for deadly infant virus

Scientists at St. Jude Children's Hospital have developed a new vaccine for Respiratory Syncytial Virus, or RSV.

It's an infection that sends thousands of infants to the hospital every year.

RSV seems like an ordinary cold, but can lead to breathing difficulty and pneumonia, especially for pre-mature infants, or those with chronic ailments.

St. Jude is testing the vaccine in India, where RSV kills more than 100,000 children every year.

Right now, there's no approved vaccine.

----------

Send a breaking news alert
Report a correction or typo
Learn more about the 6abc apps